Evidence to Support CBD in Diseases of High Mortality: Rationale for Polypharmacy
Time: 4:30 pm
day: Day One
Details:
- In depth discussion of late breaking data comparing CBD isolate to cannflavins and cannabinoids used in combination in the Tau model of neurodegenerative disease
- Rationale and evidence for the long-term use of cannabinoids use in diseases with high mortality
- Analyzing the nuance of cannabinoid rational polypharmacy, "entourage vs non-tourage"
